Pricing Johnson & Johnson’s Patenting & Pricing Strategy for TB Medicine Bedaquiline: A Cautionary Tale for New TB Medicines [GUEST ESSAY] Newsletter Edition #200 [The Curated Primer] By Priti Patnaik / 6 Oct 2023
![Johnson & Johnson’s Patenting & Pricing Strategy for TB Medicine Bedaquiline: A Cautionary Tale for New TB Medicines [GUEST ESSAY]](/content/images/size/w30/substack-post-media-s3-amazonaws-com/public/images/f36f3802-bd56-4ad0-bc72-fe2fe0929e3d_4032x3024.jpg)
![Johnson & Johnson’s Patenting & Pricing Strategy for TB Medicine Bedaquiline: A Cautionary Tale for New TB Medicines [GUEST ESSAY]](/content/images/size/w960/format/webp/substack-post-media-s3-amazonaws-com/public/images/f36f3802-bd56-4ad0-bc72-fe2fe0929e3d_4032x3024.jpg)